Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT01590849
Other study ID # nisenbaum1
Secondary ID
Status Active, not recruiting
Phase Phase 3
First received April 30, 2012
Last updated May 2, 2012
Start date January 2011

Study information

Verified date May 2012
Source Instituto do Coracao
Contact n/a
Is FDA regulated No
Health authority Brazil: Ethics Committee
Study type Interventional

Clinical Trial Summary

The use of combined oral contraceptives has been associated with increased risk of adverse cardiovascular events. The exact mechanism by which these drugs exert this influence is uncertain. It is possible that changes in autonomic nervous system are involved. The objective of these study was to evaluate the effect of the use of a contraceptive containing 20 mcg of ethinyl estradiol and 3mg of drospirenone in the autonomic nervous system in healthy women. Few studies have been conducted in the field of hormonal contraception and evaluation of the autonomic nervous system work and no prospective, controlled study was published so far. These study will be the first.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 69
Est. completion date
Est. primary completion date May 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 20 Years to 40 Years
Eligibility Inclusion Criteria:

- 20 to 40 years old

- no use of hormonal contraceptives for at least 6 months before the study

- need for contraceptive method

- willingness to participate in the study

Exclusion Criteria:

- positive pregnancy test

- category 3 or 4 classification on WHO's Medical Eligibility Criteria for Contraceptive

- smoking

- obesity

- fasting glucose above 100 mg/dL

- abnormalities in lipid profile

- use of other medications

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor)


Related Conditions & MeSH terms

  • Contraceptive Affecting Blood Pressure
  • Contraceptive Affecting the Autonomic Nervous System

Intervention

Drug:
Contraceptives, Oral, Combined (Yaz®)
After a counseling session concerning the advantages, disadvantages and side effects of contraceptive methods (COC or nonhormonal methods), the volunteers were divided into two study groups according to the method they chose to use as follows: Case group: healthy women, users of COC containing 20 mcg ethynil estradiol and 3 mg drospirenone , 24 days of active pills, 4 days of pill-free interval (n=40). Control group: healthy women, users of nonhormonal methods of contraception (condoms or copper IUD) (n=40). Subjects were tested once before the introduction of the contraceptive method and again after 6 months of its use.

Locations

Country Name City State
Brazil Marcelo Gil Nisenbaum Sao Paulo São Paulo

Sponsors (1)

Lead Sponsor Collaborator
Instituto do Coracao

Country where clinical trial is conducted

Brazil, 

References & Publications (2)

Carter JR, Klein JC, Schwartz CE. Effects of oral contraceptives on sympathetic nerve activity during orthostatic stress in young, healthy women. Am J Physiol Regul Integr Comp Physiol. 2010 Jan;298(1):R9-R14. doi: 10.1152/ajpregu.00554.2009. Epub 2009 Oct 14. — View Citation

Minson CT, Halliwill JR, Young TM, Joyner MJ. Sympathetic activity and baroreflex sensitivity in young women taking oral contraceptives. Circulation. 2000 Sep 26;102(13):1473-6. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary combined hormonal oral contraceptive with drospirenone and its influence on the autonomic nervous system The participants in this study will be 80 healthy women. After a counseling session concerning the advantages, disadvantages and side effects of contraceptive methods (COC or nonhormonal methods), the volunteers were divided into two study groups according to the method they chose to use as follows:
Case group: healthy women, users of COC containing 20 mcg EE and 3 mg DRSP (Yaz®)(n=40).
Control group: healthy women, users of nonhormonal methods of contraception (condoms or copper IUD) (n=40).
The acquisition of autonomic parameters will be performed through the device Finometer.
six months after the intervention Yes
Secondary combined hormonal oral contraceptive with drospirenone and its influence on blood pressure six month after the intervention Yes